Medtronic’s market dominance under threat as Adagio Medicals cryoablation catheter successfully treats its first patients, says GlobalData

Following the recent announcement that Adagio Medical, Inc. have successfully treated their first patients with its new One Shot+ cryoablation catheter,

Sheryl Tang, Senior Analyst for Medical Devices at GlobalData, offers her view on what this means for the market:

“The cryoablation market is set for disruption as Adagio Medical, Boston Scientific and a number of other smaller companies enter the space to challenge the market dominance of Medtronic’s devices.

“The global electrophysiology ablation catheters market is relatively new and fast growing, with cryoablation catheters contributing 27% of market value and growing at an impressive compound annual growth rate (CAGR) of 5%, according to the latest research by GlobalData.

‘‘In the face of this new competition, Medtronic will need to leverage their reputation and the provenance of their cryoablation device in order to protect and maintain their market dominance.’’


For more information

To gain access to our latest press releases: GlobalData Media Centre

Analysts available for comment. Please contact the GlobalData Press Office:


EMEA & Americas: +44 (0)207 832 4399

Asia-Pacific: +91 40 6616 6809

To gain access to our latest press releases and expert analysis on developments in your industry, please connect with us on: | LinkedIn | Twitter

About GlobalData

4,000 of the world’s largest companies, including over 70% of FTSE 100 and 60% of Fortune 100 companies, make more timely and better business decisions thanks to GlobalData’s unique data, expert analysis and innovative solutions, all in one platform. GlobalData’s mission is to help our clients decode the future to be more successful and innovative across a range of industries, including the healthcare, consumer, retail, financial, technology, energy and professional services sectors. PR3043

More Media